Acquiring Company
CONMED Corporation
Acquired Company
Biorez, Inc.
Description
CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be financed through the company's existing credit facility. The transaction is expected to close in early August 2022.
Fundz sees it the moment CONMED Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biorez, Inc.?
Biorez, Inc. was acquired by CONMED Corporation, based in Tampa Bay. The deal was reported on August 1, 2022. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED Corporation is publicly traded (CNMD) and operates in Manufacturing.
When did CONMED Corporation acquire Biorez, Inc.?
CONMED Corporation's acquisition of Biorez, Inc. was reported on August 1, 2022. CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biorez, Inc. do?
Biorez is a New Haven, CT based medical device start-up focused on advancing the healing of soft tissues using its proprietary BioBrace® Implant technology. It is privately held, operating in Biotechnology, and is based in New Haven.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.